CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $182,793
- in 3 filings
Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-31 | Henderson Molly Chief Financial Officer | Grant or award · Restricted Stock Units | +7,500 | 7,500 | ||
| 2022-01-31 | Henderson Molly Chief Financial Officer | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-01-31 | Schoenberg Mark Chief Medical Officer | Exercise or conversion | +500 | 22,595 | ||
| 2022-01-31 | Schoenberg Mark Chief Medical Officer | Sale | −275 | $7.58 | $2K | 22,320 |
| 2022-01-31 | Schoenberg Mark Chief Medical Officer | Exercise or conversion | +2,000 | 24,320 | ||
| 2022-01-31 | Schoenberg Mark Chief Medical Officer | Sale | −1,099 | $7.58 | $8K | 23,221 |
| 2022-01-31 | Schoenberg Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −500 | 2,000 | ||
| 2022-01-31 | Schoenberg Mark Chief Medical Officer | Grant or award · Stock Option (right to buy) | +12,064 | 12,064 | ||
| 2022-01-31 | Schoenberg Mark Chief Medical Officer | Grant or award · Restricted Stock Units | +4,000 | 4,000 | ||
| 2022-01-31 | Schoenberg Mark Chief Medical Officer | Exercise or conversion · Restricted Stock | −2,000 | 4,000 | ||
| 2022-01-31 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion | +5,000 | 303,220 | ||
| 2022-01-31 | Barrett Elizabeth A. Chief Executive Officer | Sale | −2,235 | $7.58 | $17K | 300,985 |
| 2022-01-31 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion | +13,333 | 314,318 | ||
| 2022-01-31 | Barrett Elizabeth A. Chief Executive Officer | Sale | −5,960 | $7.58 | $45K | 308,358 |
| 2022-01-31 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −5,000 | 5,000 | ||
| 2022-01-31 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −13,333 | 26,667 | ||
| 2022-01-31 | Barrett Elizabeth A. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2022-01-26 | Schoenberg Mark Chief Medical Officer | Exercise or conversion | +209 | 22,206 | ||
| 2022-01-26 | Schoenberg Mark Chief Medical Officer | Sale | −111 | $8.09 | $898 | 22,095 |
| 2022-01-26 | Schoenberg Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −209 | 0 |
Page 14 of 25 · 496 trades